Brief: Spago Nanomedical Q2 Sales SEK 81 Thousand
Aug 20 (Reuters) - Spago Nanomedical Q2 operating expenses SEK -8.291 million. Q2 adjusted EPS SEK -0.02 Q2 net income SEK -6.964 million
Aug 20 (Reuters) - Spago Nanomedical Q2 operating expenses SEK -8.291 million. Q2 adjusted EPS SEK -0.02 Q2 net income SEK -6.964 million